Promoter News and Research

RSS

Gene therapy to prevent stillbirth and premature delivery developed

Researchers investigate the effectiveness of placental nano-based insulin-like 1 growth factor gene therapy to correct fetal growth restriction.

12 Dec 2024

Study reveals how DNA folding drives gene activity bursts

Researchers at Kyushu University have revealed how spatial distance between specific regions of DNA is linked to bursts of gene activity.

6 Dec 2024

Aging of lung stem cells drives iron deficiency and reduces capacity for tumor formation

Aging induces iron deficiency, reducing stem cell function and tumor growth while enhancing ferroptosis resistance, revealing new cancer prevention strategies.

5 Dec 2024

STAG2 loss linked to increased aggression in Ewing sarcoma

Ewing sarcoma is a tumor of the bones and soft tissues that occurs in children and young people. Like all childhood cancers, it is rare – 9 to 10 cases per million inhabitants per year – but it is very aggressive. 25% of patients do not respond well to regular therapy and they often experience relapses.

29 Nov 2024

Antibiotic activity altered by interaction with nanoplastics, new research shows

Nanoplastics significantly alter antibiotic interactions, reducing effectiveness and increasing resistance, posing serious implications for health and ecology.

20 Nov 2024

Growth hormone-releasing hormone transforms therapeutic potential in health and chronic disease

Researchers review the biological activities of growth hormone-releasing hormone and its analogs.

17 Nov 2024

Curcumin compound reactivates Epstein–Barr virus, offering safer cancer therapy

A novel curcumin derivative, C210, activates the Epstein–Barr virus (EBV) lytic cycle without producing infectious virions by disrupting HSP90. This discovery opens avenues for safer EBV-positive cancer therapies.

5 Nov 2024

MGI and OncoDNA join forces to offer laboratories a streamlined NGS workflow for implementing Comprehensive Genomic Profiling (CGP) OncoDEEP® Kit in clinical practice

MGI (MGI Tech Co., Ltd. or its subsidiaries, together referred to MGI), a company committed to building core tools and technologies that drive innovation in life science, today announced the collaboration with OncoDNA, a genomic and theranostic company specializing in precision medicine for the treatment of cancer and genetic diseases.

From MGI 29 Oct 2024

Semaglutide enhances cognitive abilities and reduces Alzheimer’s pathology in mice and human brain models

Researchers find that Semaglutide improves cognitive function and reduces amyloid and tau pathology in Alzheimer's disease models, while restoring oxytocin levels in both mice and human brain organoids.

14 Oct 2024

Transposable elements found to be dysregulated in Alzheimer's brains, revealing potential targets for therapy

Study reveals widespread dysregulation of transposable elements (TEs) in aging human brains with Alzheimer's disease, using advanced techniques like CRISPR interference to identify TE-related risk genes.

9 Oct 2024

Groundbreaking study challenges treatment protocols for glioblastoma in older adults

A groundbreaking study led by Dr Monika E. Hegi, MD, PhD and European Organisation for Research and Treatment of Cancer (EORTC) headquarters team (Felix Oppong Msc, Dr Thierry Gorlia, PhD) reveals that older adults glioblastoma patients with truly unmethylated MGMT promoter do not benefit from temozolomide (TMZ) treatment, challenging current treatment protocols and paving the way for more personalised therapies.

9 Oct 2024

The threat of serous uterine cancer: A new perspective

Most uterine cancers have excellent five-year survival rates – up to 95% for localized cancer. Serous uterine cancer is an exception, with five-year survival rates of 35% to 50% for stage 1 or 2 cancer.

3 Oct 2024

Study highlights the role of genetic factors in COVID-19 thrombosis and inflammation

Despite global vaccination efforts, COVID-19 continues to pose significant risks, leading to severe complications and fatalities. These risks are driven by disrupted coagulation, impaired fibrinolysis, which is the process of breaking blood clots, and heightened inflammatory responses.

3 Oct 2024

Why children with Down’s syndrome are predisposed to developing leukaemia

The study uncovers mechanisms linking Down syndrome to leukemia, emphasizing the role of oxidative stress and genetic alterations in fetal blood development.

26 Sep 2024

Breakthrough research offers hope for improved treatment of chronic wounds

Novel research, presented today at the European Academy of Dermatology and Venereology (EADV) Congress 2024, has identified key molecular targets that could significantly enhance the healing of both acute and chronic wounds.

25 Sep 2024

Digital health investment could save millions from noncommunicable diseases

An investment today of an additional US$0.24 per patient per year in digital health interventions, such as telemedicine, mobile messaging and chatbots, can help save more than 2 million lives from noncommunicable diseases over the next decade, says a new report released jointly by the World Health Organization (WHO) and ITU (International Telecommunication Union).

23 Sep 2024

Promoter News and Research

Gene therapy to prevent stillbirth and premature delivery developed

Study reveals how DNA folding drives gene activity bursts

Aging of lung stem cells drives iron deficiency and reduces capacity for tumor formation

STAG2 loss linked to increased aggression in Ewing sarcoma

Antibiotic activity altered by interaction with nanoplastics, new research shows

Growth hormone-releasing hormone transforms therapeutic potential in health and chronic disease

Curcumin compound reactivates Epstein–Barr virus, offering safer cancer therapy

MGI and OncoDNA join forces to offer laboratories a streamlined NGS workflow for implementing Comprehensive Genomic Profiling (CGP) OncoDEEP® Kit in clinical practice

Semaglutide enhances cognitive abilities and reduces Alzheimer’s pathology in mice and human brain models

Transposable elements found to be dysregulated in Alzheimer's brains, revealing potential targets for therapy

Groundbreaking study challenges treatment protocols for glioblastoma in older adults

The threat of serous uterine cancer: A new perspective

Study highlights the role of genetic factors in COVID-19 thrombosis and inflammation

Why children with Down’s syndrome are predisposed to developing leukaemia

Breakthrough research offers hope for improved treatment of chronic wounds

Digital health investment could save millions from noncommunicable diseases

Mediterranean diet during pregnancy reduces childhood obesity risk

PPARs and PROTACs: A new strategy in cancer therapeutics

Disrupted glucose transport in oligodendrocytes linked to myelin thinning and aging in new research

Scientists reveal how DNA methylation drives astrocytes to become stem cells, unlocking new potential for brain repair

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News